The global market for Spinal Fusion Biologics was valued at US$ 2349 million in the year 2024 and is projected to reach a revised size of US$ 3290 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Spinal Fusion Biologics Market

Spinal biologics are an important component of lumbar interbody spine fusion. Biologics are substances that work to alter the local environment by affecting cellular activity, growth, and differentiation through inherent properties of osteogenesis, osteoinduction, and osteoconduction.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Spinal Fusion Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal Fusion Biologics.

The Spinal Fusion Biologics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Spinal Fusion Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Spinal Fusion Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Spinal Fusion Biologics Market Report

Report Metric	Details
Report Name	Spinal Fusion Biologics Market
Accounted market size in year	US$ 2349 million
Forecasted market size in 2031	US$ 3290 million
CAGR	5.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Bone Graft Bone Graft Substitute Platelet Rich Plasma (PRP) Other
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, J & J, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine, K2M, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Spinal Fusion Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Spinal Fusion Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Spinal Fusion Biologics Market growing?

Ans: The Spinal Fusion Biologics Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Spinal Fusion Biologics Market size in 2031?

Ans: The Spinal Fusion Biologics Market size in 2031 will be US$ 3290 million.

Who are the main players in the Spinal Fusion Biologics Market report?

Ans: The main players in the Spinal Fusion Biologics Market are Medtronic, J & J, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine, K2M, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex

What are the Application segmentation covered in the Spinal Fusion Biologics Market report?

Ans: The Applications covered in the Spinal Fusion Biologics Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Spinal Fusion Biologics Market report?

Ans: The Types covered in the Spinal Fusion Biologics Market report are Bone Graft, Bone Graft Substitute, Platelet Rich Plasma (PRP), Other

1 Spinal Fusion Biologics Market Overview

1.1 Product Definition

1.2 Spinal Fusion Biologics by Type

1.2.1 Global Spinal Fusion Biologics Market Value Comparison by Type (2024 VS 2031)

1.2.2 Bone Graft

1.2.3 Bone Graft Substitute

1.2.4 Platelet Rich Plasma (PRP)

1.2.5 Other

1.3 Spinal Fusion Biologics by Application

1.3.1 Global Spinal Fusion Biologics Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Spinal Fusion Biologics Market Size Estimates and Forecasts

1.4.1 Global Spinal Fusion Biologics Revenue 2020-2031

1.4.2 Global Spinal Fusion Biologics Sales 2020-2031

1.4.3 Global Spinal Fusion Biologics Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Spinal Fusion Biologics Market Competition by Manufacturers

2.1 Global Spinal Fusion Biologics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Spinal Fusion Biologics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Spinal Fusion Biologics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Spinal Fusion Biologics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Spinal Fusion Biologics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Spinal Fusion Biologics, Product Type & Application

2.7 Global Key Manufacturers of Spinal Fusion Biologics, Date of Enter into This Industry

2.8 Global Spinal Fusion Biologics Market Competitive Situation and Trends

2.8.1 Global Spinal Fusion Biologics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Spinal Fusion Biologics Players Market Share by Revenue

2.8.3 Global Spinal Fusion Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Spinal Fusion Biologics Market Scenario by Region

3.1 Global Spinal Fusion Biologics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Spinal Fusion Biologics Sales by Region: 2020-2031

3.2.1 Global Spinal Fusion Biologics Sales by Region: 2020-2025

3.2.2 Global Spinal Fusion Biologics Sales by Region: 2026-2031

3.3 Global Spinal Fusion Biologics Revenue by Region: 2020-2031

3.3.1 Global Spinal Fusion Biologics Revenue by Region: 2020-2025

3.3.2 Global Spinal Fusion Biologics Revenue by Region: 2026-2031

3.4 North America Spinal Fusion Biologics Market Facts & Figures by Country

3.4.1 North America Spinal Fusion Biologics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Spinal Fusion Biologics Sales by Country (2020-2031)

3.4.3 North America Spinal Fusion Biologics Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Spinal Fusion Biologics Market Facts & Figures by Country

3.5.1 Europe Spinal Fusion Biologics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Spinal Fusion Biologics Sales by Country (2020-2031)

3.5.3 Europe Spinal Fusion Biologics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Spinal Fusion Biologics Market Facts & Figures by Region

3.6.1 Asia Pacific Spinal Fusion Biologics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Spinal Fusion Biologics Sales by Region (2020-2031)

3.6.3 Asia Pacific Spinal Fusion Biologics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Spinal Fusion Biologics Market Facts & Figures by Country

3.7.1 Latin America Spinal Fusion Biologics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Spinal Fusion Biologics Sales by Country (2020-2031)

3.7.3 Latin America Spinal Fusion Biologics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Spinal Fusion Biologics Market Facts & Figures by Country

3.8.1 Middle East and Africa Spinal Fusion Biologics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Spinal Fusion Biologics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Spinal Fusion Biologics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Spinal Fusion Biologics Sales by Type (2020-2031)

4.1.1 Global Spinal Fusion Biologics Sales by Type (2020-2025)

4.1.2 Global Spinal Fusion Biologics Sales by Type (2026-2031)

4.1.3 Global Spinal Fusion Biologics Sales Market Share by Type (2020-2031)

4.2 Global Spinal Fusion Biologics Revenue by Type (2020-2031)

4.2.1 Global Spinal Fusion Biologics Revenue by Type (2020-2025)

4.2.2 Global Spinal Fusion Biologics Revenue by Type (2026-2031)

4.2.3 Global Spinal Fusion Biologics Revenue Market Share by Type (2020-2031)

4.3 Global Spinal Fusion Biologics Price by Type (2020-2031)

5 Segment by Application

5.1 Global Spinal Fusion Biologics Sales by Application (2020-2031)

5.1.1 Global Spinal Fusion Biologics Sales by Application (2020-2025)

5.1.2 Global Spinal Fusion Biologics Sales by Application (2026-2031)

5.1.3 Global Spinal Fusion Biologics Sales Market Share by Application (2020-2031)

5.2 Global Spinal Fusion Biologics Revenue by Application (2020-2031)

5.2.1 Global Spinal Fusion Biologics Revenue by Application (2020-2025)

5.2.2 Global Spinal Fusion Biologics Revenue by Application (2026-2031)

5.2.3 Global Spinal Fusion Biologics Revenue Market Share by Application (2020-2031)

5.3 Global Spinal Fusion Biologics Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Company Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Medtronic Spinal Fusion Biologics Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 J & J

6.2.1 J & J Company Information

6.2.2 J & J Description and Business Overview

6.2.3 J & J Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 J & J Spinal Fusion Biologics Product Portfolio

6.2.5 J & J Recent Developments/Updates

6.3 Stryker Corporation

6.3.1 Stryker Corporation Company Information

6.3.2 Stryker Corporation Description and Business Overview

6.3.3 Stryker Corporation Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Stryker Corporation Spinal Fusion Biologics Product Portfolio

6.3.5 Stryker Corporation Recent Developments/Updates

6.4 Nuvasive

6.4.1 Nuvasive Company Information

6.4.2 Nuvasive Description and Business Overview

6.4.3 Nuvasive Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Nuvasive Spinal Fusion Biologics Product Portfolio

6.4.5 Nuvasive Recent Developments/Updates

6.5 Zimmer Biomet

6.5.1 Zimmer Biomet Company Information

6.5.2 Zimmer Biomet Description and Business Overview

6.5.3 Zimmer Biomet Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Zimmer Biomet Spinal Fusion Biologics Product Portfolio

6.5.5 Zimmer Biomet Recent Developments/Updates

6.6 Orthofix International

6.6.1 Orthofix International Company Information

6.6.2 Orthofix International Description and Business Overview

6.6.3 Orthofix International Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Orthofix International Spinal Fusion Biologics Product Portfolio

6.6.5 Orthofix International Recent Developments/Updates

6.7 Globus Medical

6.7.1 Globus Medical Company Information

6.7.2 Globus Medical Description and Business Overview

6.7.3 Globus Medical Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Globus Medical Spinal Fusion Biologics Product Portfolio

6.7.5 Globus Medical Recent Developments/Updates

6.8 alphatec spine

6.8.1 alphatec spine Company Information

6.8.2 alphatec spine Description and Business Overview

6.8.3 alphatec spine Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.8.4 alphatec spine Spinal Fusion Biologics Product Portfolio

6.8.5 alphatec spine Recent Developments/Updates

6.9 K2M

6.9.1 K2M Company Information

6.9.2 K2M Description and Business Overview

6.9.3 K2M Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.9.4 K2M Spinal Fusion Biologics Product Portfolio

6.9.5 K2M Recent Developments/Updates

6.10 Exactech

6.10.1 Exactech Company Information

6.10.2 Exactech Description and Business Overview

6.10.3 Exactech Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Exactech Spinal Fusion Biologics Product Portfolio

6.10.5 Exactech Recent Developments/Updates

6.11 Wright Medical Technology

6.11.1 Wright Medical Technology Company Information

6.11.2 Wright Medical Technology Description and Business Overview

6.11.3 Wright Medical Technology Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Wright Medical Technology Spinal Fusion Biologics Product Portfolio

6.11.5 Wright Medical Technology Recent Developments/Updates

6.12 X-Spine

6.12.1 X-Spine Company Information

6.12.2 X-Spine Description and Business Overview

6.12.3 X-Spine Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.12.4 X-Spine Spinal Fusion Biologics Product Portfolio

6.12.5 X-Spine Recent Developments/Updates

6.13 Nutech

6.13.1 Nutech Company Information

6.13.2 Nutech Description and Business Overview

6.13.3 Nutech Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Nutech Spinal Fusion Biologics Product Portfolio

6.13.5 Nutech Recent Developments/Updates

6.14 Arthrex

6.14.1 Arthrex Company Information

6.14.2 Arthrex Description and Business Overview

6.14.3 Arthrex Spinal Fusion Biologics Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Arthrex Spinal Fusion Biologics Product Portfolio

6.14.5 Arthrex Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Spinal Fusion Biologics Industry Chain Analysis

7.2 Spinal Fusion Biologics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Spinal Fusion Biologics Production Mode & Process Analysis

7.4 Spinal Fusion Biologics Sales and Marketing

7.4.1 Spinal Fusion Biologics Sales Channels

7.4.2 Spinal Fusion Biologics Distributors

7.5 Spinal Fusion Biologics Customer Analysis

8 Spinal Fusion Biologics Market Dynamics

8.1 Spinal Fusion Biologics Industry Trends

8.2 Spinal Fusion Biologics Market Drivers

8.3 Spinal Fusion Biologics Market Challenges

8.4 Spinal Fusion Biologics Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Zimmer Biomet

Arthrex

J & J

Stryker Corporation

NuVasive

Orthofix International

Wright Medical Technology

X-Spine

Nutech

List of Tables

Table 1. Global Spinal Fusion Biologics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Spinal Fusion Biologics Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Spinal Fusion Biologics Market Competitive Situation by Manufacturers in 2024

Table 4. Global Spinal Fusion Biologics Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Spinal Fusion Biologics Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Spinal Fusion Biologics Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Spinal Fusion Biologics Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Spinal Fusion Biologics Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Spinal Fusion Biologics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Spinal Fusion Biologics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Spinal Fusion Biologics, Product Type & Application

Table 12. Global Key Manufacturers of Spinal Fusion Biologics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Spinal Fusion Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Fusion Biologics as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Spinal Fusion Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Spinal Fusion Biologics Sales by Region (2020-2025) & (K Units)

Table 18. Global Spinal Fusion Biologics Sales Market Share by Region (2020-2025)

Table 19. Global Spinal Fusion Biologics Sales by Region (2026-2031) & (K Units)

Table 20. Global Spinal Fusion Biologics Sales Market Share by Region (2026-2031)

Table 21. Global Spinal Fusion Biologics Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Spinal Fusion Biologics Revenue Market Share by Region (2020-2025)

Table 23. Global Spinal Fusion Biologics Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Spinal Fusion Biologics Revenue Market Share by Region (2026-2031)

Table 25. North America Spinal Fusion Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Spinal Fusion Biologics Sales by Country (2020-2025) & (K Units)

Table 27. North America Spinal Fusion Biologics Sales by Country (2026-2031) & (K Units)

Table 28. North America Spinal Fusion Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Spinal Fusion Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Spinal Fusion Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Spinal Fusion Biologics Sales by Country (2020-2025) & (K Units)

Table 32. Europe Spinal Fusion Biologics Sales by Country (2026-2031) & (K Units)

Table 33. Europe Spinal Fusion Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Spinal Fusion Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Spinal Fusion Biologics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Spinal Fusion Biologics Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Spinal Fusion Biologics Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Spinal Fusion Biologics Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Spinal Fusion Biologics Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Spinal Fusion Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Spinal Fusion Biologics Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Spinal Fusion Biologics Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Spinal Fusion Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Spinal Fusion Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Spinal Fusion Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Spinal Fusion Biologics Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Spinal Fusion Biologics Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Spinal Fusion Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Spinal Fusion Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Spinal Fusion Biologics Sales (K Units) by Type (2020-2025)

Table 51. Global Spinal Fusion Biologics Sales (K Units) by Type (2026-2031)

Table 52. Global Spinal Fusion Biologics Sales Market Share by Type (2020-2025)

Table 53. Global Spinal Fusion Biologics Sales Market Share by Type (2026-2031)

Table 54. Global Spinal Fusion Biologics Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Spinal Fusion Biologics Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Spinal Fusion Biologics Revenue Market Share by Type (2020-2025)

Table 57. Global Spinal Fusion Biologics Revenue Market Share by Type (2026-2031)

Table 58. Global Spinal Fusion Biologics Price (US$/Unit) by Type (2020-2025)

Table 59. Global Spinal Fusion Biologics Price (US$/Unit) by Type (2026-2031)

Table 60. Global Spinal Fusion Biologics Sales (K Units) by Application (2020-2025)

Table 61. Global Spinal Fusion Biologics Sales (K Units) by Application (2026-2031)

Table 62. Global Spinal Fusion Biologics Sales Market Share by Application (2020-2025)

Table 63. Global Spinal Fusion Biologics Sales Market Share by Application (2026-2031)

Table 64. Global Spinal Fusion Biologics Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Spinal Fusion Biologics Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Spinal Fusion Biologics Revenue Market Share by Application (2020-2025)

Table 67. Global Spinal Fusion Biologics Revenue Market Share by Application (2026-2031)

Table 68. Global Spinal Fusion Biologics Price (US$/Unit) by Application (2020-2025)

Table 69. Global Spinal Fusion Biologics Price (US$/Unit) by Application (2026-2031)

Table 70. Medtronic Company Information

Table 71. Medtronic Description and Business Overview

Table 72. Medtronic Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Medtronic Spinal Fusion Biologics Product

Table 74. Medtronic Recent Developments/Updates

Table 75. J & J Company Information

Table 76. J & J Description and Business Overview

Table 77. J & J Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. J & J Spinal Fusion Biologics Product

Table 79. J & J Recent Developments/Updates

Table 80. Stryker Corporation Company Information

Table 81. Stryker Corporation Description and Business Overview

Table 82. Stryker Corporation Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Stryker Corporation Spinal Fusion Biologics Product

Table 84. Stryker Corporation Recent Developments/Updates

Table 85. Nuvasive Company Information

Table 86. Nuvasive Description and Business Overview

Table 87. Nuvasive Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Nuvasive Spinal Fusion Biologics Product

Table 89. Nuvasive Recent Developments/Updates

Table 90. Zimmer Biomet Company Information

Table 91. Zimmer Biomet Description and Business Overview

Table 92. Zimmer Biomet Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Zimmer Biomet Spinal Fusion Biologics Product

Table 94. Zimmer Biomet Recent Developments/Updates

Table 95. Orthofix International Company Information

Table 96. Orthofix International Description and Business Overview

Table 97. Orthofix International Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Orthofix International Spinal Fusion Biologics Product

Table 99. Orthofix International Recent Developments/Updates

Table 100. Globus Medical Company Information

Table 101. Globus Medical Description and Business Overview

Table 102. Globus Medical Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Globus Medical Spinal Fusion Biologics Product

Table 104. Globus Medical Recent Developments/Updates

Table 105. alphatec spine Company Information

Table 106. alphatec spine Description and Business Overview

Table 107. alphatec spine Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. alphatec spine Spinal Fusion Biologics Product

Table 109. alphatec spine Recent Developments/Updates

Table 110. K2M Company Information

Table 111. K2M Description and Business Overview

Table 112. K2M Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. K2M Spinal Fusion Biologics Product

Table 114. K2M Recent Developments/Updates

Table 115. Exactech Company Information

Table 116. Exactech Description and Business Overview

Table 117. Exactech Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Exactech Spinal Fusion Biologics Product

Table 119. Exactech Recent Developments/Updates

Table 120. Wright Medical Technology Company Information

Table 121. Wright Medical Technology Description and Business Overview

Table 122. Wright Medical Technology Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Wright Medical Technology Spinal Fusion Biologics Product

Table 124. Wright Medical Technology Recent Developments/Updates

Table 125. X-Spine Company Information

Table 126. X-Spine Description and Business Overview

Table 127. X-Spine Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. X-Spine Spinal Fusion Biologics Product

Table 129. X-Spine Recent Developments/Updates

Table 130. Nutech Company Information

Table 131. Nutech Description and Business Overview

Table 132. Nutech Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Nutech Spinal Fusion Biologics Product

Table 134. Nutech Recent Developments/Updates

Table 135. Arthrex Company Information

Table 136. Arthrex Description and Business Overview

Table 137. Arthrex Spinal Fusion Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Arthrex Spinal Fusion Biologics Product

Table 139. Arthrex Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Spinal Fusion Biologics Distributors List

Table 143. Spinal Fusion Biologics Customers List

Table 144. Spinal Fusion Biologics Market Trends

Table 145. Spinal Fusion Biologics Market Drivers

Table 146. Spinal Fusion Biologics Market Challenges

Table 147. Spinal Fusion Biologics Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Spinal Fusion Biologics

Figure 2. Global Spinal Fusion Biologics Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Spinal Fusion Biologics Market Share by Type: 2024 & 2031

Figure 4. Bone Graft Product Picture

Figure 5. Bone Graft Substitute Product Picture

Figure 6. Platelet Rich Plasma (PRP) Product Picture

Figure 7. Other Product Picture

Figure 8. Global Spinal Fusion Biologics Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Spinal Fusion Biologics Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Other

Figure 13. Global Spinal Fusion Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Spinal Fusion Biologics Market Size (2020-2031) & (US$ Million)

Figure 15. Global Spinal Fusion Biologics Sales (2020-2031) & (K Units)

Figure 16. Global Spinal Fusion Biologics Average Price (US$/Unit) & (2020-2031)

Figure 17. Spinal Fusion Biologics Report Years Considered

Figure 18. Spinal Fusion Biologics Sales Share by Manufacturers in 2024

Figure 19. Global Spinal Fusion Biologics Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Spinal Fusion Biologics Players: Market Share by Revenue in Spinal Fusion Biologics in 2024

Figure 21. Spinal Fusion Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Spinal Fusion Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Spinal Fusion Biologics Sales Market Share by Country (2020-2031)

Figure 24. North America Spinal Fusion Biologics Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Spinal Fusion Biologics Sales Market Share by Country (2020-2031)

Figure 28. Europe Spinal Fusion Biologics Revenue Market Share by Country (2020-2031)

Figure 29. Germany Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Spinal Fusion Biologics Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Spinal Fusion Biologics Revenue Market Share by Region (2020-2031)

Figure 36. China Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Spinal Fusion Biologics Sales Market Share by Country (2020-2031)

Figure 47. Latin America Spinal Fusion Biologics Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Spinal Fusion Biologics Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Spinal Fusion Biologics Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Spinal Fusion Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Spinal Fusion Biologics by Type (2020-2031)

Figure 57. Global Revenue Market Share of Spinal Fusion Biologics by Type (2020-2031)

Figure 58. Global Spinal Fusion Biologics Price (US$/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Spinal Fusion Biologics by Application (2020-2031)

Figure 60. Global Revenue Market Share of Spinal Fusion Biologics by Application (2020-2031)

Figure 61. Global Spinal Fusion Biologics Price (US$/Unit) by Application (2020-2031)

Figure 62. Spinal Fusion Biologics Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Biologics in Spine Surgery Market Research Report 2025

Global Spine Biologics Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Spinal Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Spinal Fusion Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Biomaterials in Spinal Implants Market Research Report 2024

Global Innovations in Biologics and Biosimilars Market Research Report 2024

Global Lumbar Spine Fusion Market Research Report 2024

Global Biologics and Biosimilars Market Research Report 2025

Global Spinal Implants Devices Market Research Report 2024

Global Spinal Fusion Cage Market Research Report 2024

Innovative Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fusion Spine Surgery Biomaterials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Expandable Interbody Fusion System Market Research Report 2024

Global Orthoapedics Biologics Products Market Research Report 2024

Innovative Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Spine Fixation System Market Research Report 2024

Interbody Spinal Implants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Spine Surgery Biomaterials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Spinal Interbody Fusion Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »